|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute of Environmental Health Sciences (NIEHS) |
|---|---|
| Information provided by: | National Institute of Environmental Health Sciences (NIEHS) |
| ClinicalTrials.gov Identifier: | NCT00011453 |
Purpose
We are investigating the role of an enzyme (NQO1) in protection against the bone marrow toxicity of the occupational and environmental toxicant benzene. All of the proposed studies involve use of human bone marrow cells in-vitro to define mechanisms of NQO1-mediated protection. Cells are obtained from healthy volunteers and protocols have undergone IRB review and approval.
| Condition |
|---|
|
Leukemia Aplastic Anemia |
| Study Type: | Observational |
| Study Design: | Additional Descriptors: Convenience Sample Primary Purpose: Screening Time Perspective: Prospective |
| Official Title: | NQO1 in Protection Against Benzene Toxicity |
Eligibility| Ages Eligible for Study: | 21 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Healthy adult volunteers with blood counts in normal ranges and without evidence of hepatitis or HIV infection.
Contacts and Locations
More Information
| ClinicalTrials.gov Identifier: | NCT00011453 History of Changes |
| Other Study ID Numbers: | 9554-CP-001 |
| Study First Received: | February 21, 2001 |
| Last Updated: | June 23, 2005 |
| Health Authority: | United States: Federal Government |
|
NQO1 DT-diaphorase Benzene Leukemia Aplastic anemia |
|
Anemia Anemia, Aplastic Leukemia Hematologic Diseases |
Bone Marrow Diseases Neoplasms by Histologic Type Neoplasms |